BSACI guidelines for the management of chronic urticaria and angio-oedema

被引:200
作者
Powell, R. J.
Du Toit, G. L.
Siddique, N.
Leech, S. C.
Dixon, T. A.
Clark, A. T.
Mirakian, R.
Walker, S. M.
Huber, P. A. J.
Nasser, S. M.
机构
[1] Addenbrookes Hosp, Allergy Clin, Cambridge CB2 2QQ, England
[2] British Soc Allergy & Clin Immunol, London, England
[3] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Liverpool, Merseyside, England
[4] King Coll Hosp, Dept Child Hlth, London, England
[5] Kings Coll London, Guys & St Thomas Trust, Evelina Childrens Hosp, London, England
[6] Queens Med Ctr, Clin Immunol Unit, Nottingham NG7 2UH, England
关键词
allergy; angio-oedema; antihistamine; autoantibody; autoimmune; breastfeeding; BSACI; child; guideline; hypo-thyroidism; IgE; paraprotein; pregnancy; urticaria;
D O I
10.1111/j.1365-2222.2007.02678.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 [免疫学];
摘要
This guidance for the management of patients with chronic urticaria and angio-oedema has been prepared by the Standards of Care Committee (SOCC) of the British Society for Allergy and Clinical Immunology (BSACI). The guideline is based on evidence as well as on expert opinion and is aimed at both adult physicians and paediatricians practising in allergy. The recommendations are evidence graded. During the development of these guidelines, all BSACI members were included in the consultation process using a web-based system. Their comments and suggestions were carefully considered by the SOCC. Where evidence was lacking a consensus was reached by the experts on the committee. Included in this guideline are clinical classification, aetiology, diagnosis, investigations, treatment guidance with special sections on children with urticaria, and the use of antihistamines in women who are pregnant or breastfeeding. Finally, we have made recommendations for potential areas of future research.
引用
收藏
页码:631 / 650
页数:20
相关论文
共 121 条
[1]
Drug-induced angioedema without urticaria - Incidence, prevention and management [J].
Agostoni, A ;
Cicardi, M .
DRUG SAFETY, 2001, 24 (08) :599-606
[2]
ASELTON P, 1985, OBSTET GYNECOL, V65, P451
[3]
Chronic urticaria: novel clinical and serological aspects [J].
Asero, R ;
Tedeschi, A ;
Lorini, M ;
Salimbeni, R ;
Zanoletti, T ;
Miadonna, A .
CLINICAL AND EXPERIMENTAL ALLERGY, 2001, 31 (07) :1105-1110
[4]
THE NORMOCOMPLEMENTEMIC URTICARIAL VASCULITIS SYNDROME - REPORT OF A CASE AND RESPONSE TO COLCHICINE [J].
ASHERSON, RA ;
BUCHANAN, N ;
KENWRIGHT, S ;
FLETCHER, CM ;
HUGHES, GRV .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1991, 16 (06) :424-427
[5]
Improvement of chronic idiopathic urticaria with L-thyroxine:: a new TSH role in immune response? [J].
Aversano, M ;
Caiazzo, P ;
Iorio, G ;
Ponticiello, L ;
Laganá, B ;
Leccese, F .
ALLERGY, 2005, 60 (04) :489-493
[6]
The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results [J].
Bagenstose, SE ;
Levin, L ;
Bernstein, JA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (01) :134-140
[7]
Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy [J].
Baiardini, I ;
Giardini, A ;
Pasquali, M ;
Dignetti, P ;
Guerra, L ;
Specchia, C ;
Braido, F ;
Majani, G ;
Canonica, GW .
ALLERGY, 2003, 58 (07) :621-623
[8]
Baskan E Bulbul, 2004, J Dermatolog Treat, V15, P164
[9]
Consensus meeting on the definition of physical urticarias and urticarial vasculitis [J].
Black, AK ;
Lawlor, F ;
Greaves, MW .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1996, 21 (06) :424-426
[10]
Black Anne Kobza, 2002, Clin Allergy Immunol, V17, P249